Next Article
Technology
•
Jun 16, 2025
Groundbreaking leukaemia treatment marks cancer care milestone
Big news from the UK: a major clinical trial found that pairing two targeted drugs, ibrutinib and venetoclax, can treat chronic lymphocytic leukemia (CLL) without chemotherapy. After five years, 94% of patients on this combo saw no disease progression—way better than those on just one drug or standard chemo.
TL;DR
'CLL patients now have a treatment that works better'
Published in the New England Journal of Medicine, the study shows this combo is not just more effective but also easier on patients. Dr. Talha Munir, who led the research, called it "Flair trial is a milestone," since it means CLL patients now have a treatment that works better and is less tough to handle. Plus, two-thirds of people had no detectable cancer in their bone marrow after two years—much higher than with chemo.